Nuwellis, Inc.(NUWE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NUWE Nuwellis, Inc.

交易中 09-30 14:01:12 EDT

0.7354

-0.0105

-1.41%

最高0.7650	最低0.7300	成交量5.78万
今开0.7498	昨收0.7459	日振幅4.69%
总市值268.22万	流通市值254.82万	总股本364.73万
成交额4.30万	换手率1.67%	流通股本346.50万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NUWE","market":"US","secType":"STK","nameCN":"Nuwellis, Inc.","latestPrice":0.7354,"timestamp":1790790520917,"preClose":0.7459,"halted":0,"volume":57830,"delay":0,"changeRate":-0.014076954015283487,"floatShares":3464993,"shares":3647300,"eps":-145.79883,"marketStatus":"交易中","change":-0.0105,"latestTime":"09-30 14:01:12 EDT","open":0.7498,"high":0.765,"low":0.73,"amount":43021.466117,"amplitude":0.046923,"askPrice":0.7388,"askSize":500,"bidPrice":0.7227,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-145.79883,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1790798400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.7459,"preHourTrading":{"tag":"盘前","latestPrice":0.7491,"preClose":0.7459,"latestTime":"08:51 EDT","volume":3929,"amount":2870.9914149,"timestamp":1790772700524,"change":0.0032,"changeRate":0.00429,"amplitude":0.052554},"postHourTrading":{"tag":"盘后","latestPrice":0.74,"preClose":0.7459,"latestTime":"19:46 EDT","volume":6172,"amount":4592.4181,"timestamp":1790725583941,"change":-0.0059,"changeRate":-0.00791,"amplitude":0.058185},"volumeRatio":0.440508},"requestUrl":"/m/hq/s/NUWE","defaultTab":"news","newsList":[{"id":"1191865340","title":"新闻稿：Nuwellis任命Brian Johnson为质量与监管事务总监，强化组织架构","url":"https://stock-news.laohu8.com/highlight/detail?id=1191865340","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191865340?lang=zh_cn&edition=full","pubTime":"2026-09-16 20:33","pubTimestamp":1789561981,"startTime":"0","endTime":"0","summary":"明尼阿波利斯，2026年9月16日——致力于为心肾疾病患者提供解决方案的医疗技术公司Nuwellis, Inc.今日宣布，任命Brian Johnson为质量与监管事务总监。Johnson拥有13年医疗器械质量与监管领域的丰富经验，在领导质量体系、监管事务、审计及产品开发项目方面成绩斐然。随着公司持续投资于推动产品开发、商业化及心肾全周期各项目所需的核心专业能力，此次任命将显著增强Nuwellis在质量与监管层面的实力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NUWE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161145090","title":"Nuwellis携手Atrility Medical达成战略商业协议，扩充重症监护产品线","url":"https://stock-news.laohu8.com/highlight/detail?id=1161145090","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161145090?lang=zh_cn&edition=full","pubTime":"2026-08-25 20:31","pubTimestamp":1787661069,"startTime":"0","endTime":"0","summary":"Nuwellis通过与Atrility Medical签订战略商业协议，进一步拓展其在重症监护领域的产品组合。此举标志着该公司在关键医疗细分市场的布局迈出重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NUWE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111504196","title":"Nuwellis达成协议：将在西部及东南部三个销售区域开展为期六个月的联合推广","url":"https://stock-news.laohu8.com/highlight/detail?id=1111504196","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111504196?lang=zh_cn&edition=full","pubTime":"2026-08-25 20:31","pubTimestamp":1787661069,"startTime":"0","endTime":"0","summary":"Nuwellis, Inc. 宣布达成一项新协议，内容涵盖在美国西部及东南部各州的三个销售区域内，开展为期六个月的联合推广活动。此举标志着该公司在市场拓展战略上迈出重要一步，旨在强化其产品在目标地区的渗透率与品牌影响力。协议的具体条款虽未完全披露，但显然聚焦于特定地理区域的协同作战，以期通过共享资源和渠道，实现更高效的商业覆盖。此番布局，或将为Nuwellis在竞争激烈的医疗设备领域中，开辟出一条更具针对性的增长路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NUWE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120919158","title":"Nuwellis, Inc. 公布2026年第二季度财报：营收实现两位数增长，毛利率显著扩张","url":"https://stock-news.laohu8.com/highlight/detail?id=1120919158","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120919158?lang=zh_cn&edition=full","pubTime":"2026-08-13 20:02","pubTimestamp":1786622529,"startTime":"0","endTime":"0","summary":"Nuwellis, Inc. 近日发布了其2026年第二季度的财务业绩与业务亮点。报告期内，该公司聚焦于推动营收实现两位数增长，并成功扩大了毛利率。这一成绩标志着公司在核心运营指标上取得了关键性进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUWE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100783644","title":"Nuwellis宣布完成340万美元纳斯达克规则下的市价注册直接发行定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1100783644","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100783644?lang=zh_cn&edition=full","pubTime":"2026-07-31 20:39","pubTimestamp":1785501578,"startTime":"0","endTime":"0","summary":"Nuwellis, Inc. 正式对外披露，其总额为340万美元的注册直接发行已成功定价。此次发行严格遵守纳斯达克相关规定，采用市价发行的方式推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUWE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655369861","title":"NUWELLIS宣布根据纳斯达克规则，以市价定价完成340万美元的注册直接发行。","url":"https://stock-news.laohu8.com/highlight/detail?id=2655369861","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655369861?lang=zh_cn&edition=full","pubTime":"2026-07-31 20:39","pubTimestamp":1785501573,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NUWE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156794747","title":"Nuwellis宣布：其Aquadex超滤疗法替代抗凝策略获儿科前沿期刊认可，单中心回顾性研究正式接收","url":"https://stock-news.laohu8.com/highlight/detail?id=1156794747","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156794747?lang=zh_cn&edition=full","pubTime":"2026-07-30 20:01","pubTimestamp":1785412902,"startTime":"0","endTime":"0","summary":"Nuwellis, Inc.日前披露，其针对Aquadex超滤疗法所采用的替代性抗凝策略，已获得权威期刊《儿科前沿》（Frontiers in Pediatrics）的正式接纳。该研究是一项单中心回顾性分析，其核心结论为这一创新疗法提供了有力支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NUWE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121642793","title":"Nuwellis公司公布2026年第二季度初步营收，实现两位数增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1121642793","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121642793?lang=zh_cn&edition=full","pubTime":"2026-07-27 20:31","pubTimestamp":1785155476,"startTime":"0","endTime":"0","summary":"Nuwellis, Inc. 发布了2026年第二季度的初步营收数据，结果显示，该公司实现了令人瞩目的两位数增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NUWE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169379637","title":"Nuwellis获美国专利，新型导管技术旨在提升体外治疗效能","url":"https://stock-news.laohu8.com/highlight/detail?id=1169379637","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169379637?lang=zh_cn&edition=full","pubTime":"2026-07-16 20:32","pubTimestamp":1784205132,"startTime":"0","endTime":"0","summary":"Nuwellis公司成功获得一项美国专利，该专利涉及一项旨在优化体外治疗过程的新型导管技术。此项创新技术有望为相关医疗领域带来更高效、更精准的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NUWE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121872103","title":"新任Nuwellis首席执行官迈克·麦科马克致信股东，强调儿科领域持续市场拓展及创收的战略重点","url":"https://stock-news.laohu8.com/highlight/detail?id=1121872103","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121872103?lang=zh_cn&edition=full","pubTime":"2026-06-24 20:30","pubTimestamp":1782304226,"startTime":"0","endTime":"0","summary":"新任Nuwellis首席执行官迈克·麦科马克在致股东的信函中，着重阐述了公司未来的核心战略方向。其重点在于持续深化儿科领域的市场拓展，并同步推动整体营收增长。麦科马克明确了这两大优先任务，旨在巩固公司市场地位并挖掘新的增长潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUWE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175894468","title":"Nuwellis宣布1股合10股的反向拆股将于2026年6月25日生效，拆股调整后交易将于6月26日开始 - 美国证券交易委员会文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1175894468","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175894468?lang=zh_cn&edition=full","pubTime":"2026-06-24 18:04","pubTimestamp":1782295445,"startTime":"0","endTime":"0","summary":"根据向美国证券交易委员会提交的文件，医疗技术公司Nuwellis, Inc.宣布其董事会批准的1股合10股的反向股票拆分计划，将于2026年6月25日正式生效。在反向拆股生效当日，即2026年6月25日，公司普通股将以拆股调整后的新代码在纳斯达克资本市场开始交易。拆股完成后，公司的授权股本数量将按比例减少。反向拆股是上市公司为应对股价持续低于交易所要求而采取的一种常见资本结构调整手段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NUWE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198705442","title":"Nuwellis深化与南卡罗来纳州大型医疗系统合作，将在其儿童医院安装新型Aquadex Smartflow®设备","url":"https://stock-news.laohu8.com/highlight/detail?id=1198705442","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198705442?lang=zh_cn&edition=full","pubTime":"2026-06-10 20:31","pubTimestamp":1781094668,"startTime":"0","endTime":"0","summary":"Nuwellis公司宣布，其与南卡罗来纳州一家主要医疗系统的合作范围得到进一步扩展。根据最新协议，该医疗系统旗下的一家儿童医院将引入并安装Nuwellis创新的Aquadex Smartflow®设备。这一举措标志着双方在提升儿科患者液体管理医疗水平方面的协作迈入了新阶段。Aquadex Smartflow®系统旨在为临床医生提供精准、可控的超滤治疗，尤其适用于存在液体过载状况的复杂病例。此次部署有望增强该儿童医院在心力衰竭等相关领域的治疗能力，为患者提供更先进的护理方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUWE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193541870","title":"Nuwellis儿科业务2025年贡献近半美国营收，成长期里程碑已现","url":"https://stock-news.laohu8.com/highlight/detail?id=1193541870","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193541870?lang=zh_cn&edition=full","pubTime":"2026-03-31 20:33","pubTimestamp":1774960424,"startTime":"0","endTime":"0","summary":"在2025财年，Nuwellis, Inc.旗下儿科业务板块展现出强劲增长态势，其在美国市场的销售收入已逼近公司本土总营收的50%。这一占比不仅凸显了儿科产品线作为核心增长引擎的战略地位，更标志着公司业务结构优化迈入新阶段。\n通过持续深化儿科领域的产品创新与市场渗透，Nuwellis成功将这一细分市场培育为驱动业绩增长的关键力量。业绩构成的显著变化，反映出公司在专注领域战略布局的有效性，为未来可持续增长奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NUWE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171960577","title":"Nuwellis公司董事Mika Grasso与Katharyn Field即刻辞任董事会职务——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1171960577","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171960577?lang=zh_cn&edition=full","pubTime":"2026-03-28 04:58","pubTimestamp":1774645093,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会（SEC）的文件，Nuwellis, Inc.董事会成员Mika Grasso及Katharyn Field已宣布立即辞去董事职务。此项人事变动自公告之日起生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUWE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118258376","title":"Nuwellis 2024年第四季度GAAP每股收益$(0.44)，低于预期$(0.43)；销售额$232万，低于预期$246万","url":"https://stock-news.laohu8.com/highlight/detail?id=1118258376","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118258376?lang=zh_cn&edition=full","pubTime":"2025-03-11 20:42","pubTimestamp":1741696933,"startTime":"0","endTime":"0","summary":"Nuwellis报告称季度每股亏损$，未达分析师普遍预期的$，差异为2.33%。与去年同期销售额255万美元相比，下降了8.98%。以上内容来自Benzinga Earnings专栏，原文如下：Nuwellis  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 2.33 percent. This is a 99.19 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $2.32 million which missed the analyst consensus estimate of $2.46 million by 5.67 percent.  This is a 8.98 percent decrease over sales of $2.55 million ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Nuwellis 2024年第四季度GAAP每股收益$(0.44)，低于预期$(0.43)；销售额$232万，低于预期$246万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUWE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518220929","title":"Nuwellis, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518220929?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:59","pubTimestamp":1741629571,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时59分，Nuwellis, Inc.股票出现波动，股价大幅下跌5.02%。Nuwellis, Inc.股票所在的医疗器械行业中，整体跌幅为1.36%。其相关个股中，Baird Medical Investment Hldgs Ltd C/Wts 01/10/2029 、飞天兆业、Envoy Medical Inc C/Wts 29/09/2028 涨幅较大，Reshape Lifesciences, Inc.、古特拉、Tivic Health Systems, Inc.较为活跃，换手率分别为44.39%、31.56%、14.85%，振幅较大的相关个股有飞天兆业、Baird Medical Investment Hldgs Ltd C/Wts 01/10/2029 、Dih Holdings Us Inc C/Wts 20/04/2028 ，振幅分别为47.93%、38.75%、35.59%。Nuwellis, Inc.公司简介：Nuwellis Inc 是一家医疗设备公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031101593298a2d1e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031101593298a2d1e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUWEW","BK4082","NUWE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517162592","title":"Nuwellis, Inc.盘中异动 早盘大幅上涨6.40%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517162592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517162592?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:00","pubTimestamp":1741276847,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时00分，Nuwellis, Inc.股票出现波动，股价急速上涨6.40%。截至发稿，该股报1.33美元/股，成交量3.2953万股，换手率0.75%，振幅5.16%。Nuwellis, Inc.股票所在的医疗器械行业中，整体跌幅为0.96%。其相关个股中，Pavmed Inc C/Wts 30/04/2025 Class Z、古特拉、Volitionrx Limited涨幅较大，古特拉、Reshape Lifesciences, Inc.、908 Devices Inc.较为活跃，换手率分别为193.38%、12.06%、4.79%，振幅较大的相关个股有古特拉、飞天兆业、908 Devices Inc.，振幅分别为28.40%、21.21%、16.88%。Nuwellis, Inc.公司简介：Nuwellis Inc 是一家医疗设备公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000048abeb8cda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000048abeb8cda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUWE","BK4082","NUWEW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516866317","title":"Nuwellis, Inc.盘中异动 临近收盘大幅下跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516866317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516866317?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:30","pubTimestamp":1741033819,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时30分，Nuwellis, Inc.股票出现异动，股价快速下跌5.20%。截至发稿，该股报1.19美元/股，成交量8.6448万股，换手率1.98%，振幅8.00%。Nuwellis, Inc.股票所在的医疗器械行业中，整体涨幅为0.62%。其相关个股中，Adagio Medical Holdings, Inc、Ceribell, Inc.、Baird Medical Investment Hldgs Ltd C/Wts 01/10/2029 涨幅较大，Reshape Lifesciences, Inc.、Sintx Technologies, Inc.、Bluejay Diagnostics, Inc.较为活跃，换手率分别为50.37%、19.03%、12.89%，振幅较大的相关个股有Nexalin Technology Inc C/Wts 、Ainos Inc C/Wts 29/07/2027 、Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 ，振幅分别为71.96%、59.09%、40.86%。Nuwellis, Inc.公司简介：Nuwellis Inc 是一家医疗设备公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304043020a25da34e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304043020a25da34e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NUWE","BK4082","NUWEW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514485619","title":"Nuwellis, Inc.盘中异动 早盘急速上涨7.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514485619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514485619?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:30","pubTimestamp":1740580204,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时30分，Nuwellis, Inc.股票出现波动，股价快速上涨7.56%。截至发稿，该股报1.28美元/股，成交量2.1941万股，换手率0.50%，振幅0.00%。Nuwellis, Inc.股票所在的医疗器械行业中，整体涨幅为0.00%。其相关个股中，Zomedica Corp.、Zimvie Inc.、齐默巴奥米特控股涨幅较大，Biomerica, Inc.、Venus Concept Inc.、Reshape Lifesciences, Inc.较为活跃，换手率分别为8.64%、7.03%、4.68%，振幅较大的相关个股有Zomedica Corp.、Zimvie Inc.、齐默巴奥米特控股，振幅分别为0.00%、0.00%、0.00%。Nuwellis, Inc.公司简介：Nuwellis Inc 是一家医疗设备公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223005abddec23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223005abddec23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","NUWEW","NUWE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514016689","title":"Nuwellis, Inc.盘中异动 早盘快速下跌5.56%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514016689?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:28","pubTimestamp":1740497339,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时28分，Nuwellis, Inc.股票出现异动，股价急速下挫5.56%。截至发稿，该股报1.19美元/股，成交量7.1474万股，换手率1.63%，振幅3.94%。Nuwellis, Inc.股票所在的医疗器械行业中，整体跌幅为0.43%。其相关个股中，Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 、Adapthealth Corp.、Biosig Technologies, Inc.涨幅较大，Reshape Lifesciences, Inc.、Sintx Technologies, Inc.、Bluejay Diagnostics, Inc.较为活跃，换手率分别为44.83%、6.54%、4.15%，振幅较大的相关个股有Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 、Pavmed Inc C/Wts 30/04/2025 Class Z、Biosig Technologies, Inc.，振幅分别为125.32%、37.14%、31.19%。Nuwellis, Inc.公司简介：Nuwellis Inc 是一家医疗设备公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232859a25394d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232859a25394d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","NUWE","NUWEW"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nuwellis.com","stockEarnings":[{"period":"1week","weight":-0.0973},{"period":"1month","weight":-0.1609},{"period":"3month","weight":-0.7625},{"period":"6month","weight":-0.9804},{"period":"1year","weight":-0.994},{"period":"ytd","weight":-0.9878}],"compareEarnings":[{"period":"1week","weight":-0.0119},{"period":"1month","weight":-0.0067},{"period":"3month","weight":0.0247},{"period":"6month","weight":0.1652},{"period":"1year","weight":0.1515},{"period":"ytd","weight":0.1207}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nuwellis, Inc.在2002年8月22日在特拉华州注册成立。该公司在1999年11月通过Sunshine Heart, Inc.私人有限公司开始运作，目前是Sunshine Heart, Inc. Pte Ltd.在澳大利亚的全资子公司。Nuwellis是一家医疗技术公司，致力于通过科学、合作和创新技术改善体液超负荷患者的生活。Nuwellis致力于通过为患者提供更早期、更安全、更可控的体液管理，来推进心肾护理的发展。该公司专注于开发、生产和销售用于超滤疗法的医疗器械，包括Aquadex FlexFlow和Aquadex SmartFlow系统（统称为“Aquadex 系统”）。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.020576},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.080571},{"month":3,"riseRate":0.2,"avgChangeRate":-0.240568},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.130274},{"month":5,"riseRate":0.2,"avgChangeRate":-0.088995},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.160438},{"month":7,"riseRate":0.333333,"avgChangeRate":0.151875},{"month":8,"riseRate":0.2,"avgChangeRate":-0.051912},{"month":9,"riseRate":0.2,"avgChangeRate":-0.202601},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.207973},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.144111},{"month":12,"riseRate":0.214286,"avgChangeRate":-0.103339}],"exchange":"NASDAQ","name":"Nuwellis, Inc.","nameEN":"Nuwellis, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nuwellis, Inc.(NUWE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nuwellis, Inc.(NUWE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nuwellis, Inc.,NUWE,Nuwellis, Inc.股票,Nuwellis, Inc.股票老虎,Nuwellis, Inc.股票老虎国际,Nuwellis, Inc.行情,Nuwellis, Inc.股票行情,Nuwellis, Inc.股价,Nuwellis, Inc.股市,Nuwellis, Inc.股票价格,Nuwellis, Inc.股票交易,Nuwellis, Inc.股票购买,Nuwellis, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nuwellis, Inc.(NUWE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nuwellis, Inc.(NUWE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}